Drug intelligence / Profile preview

SUSP-TESTO 100

Development stage
Unknown
Lead developer
Sinovo
Modality
Small Molecules
Administration
Intramuscular
01

Overview

SUSP-TESTO 100 is an injectable testosterone suspension marketed by Sinovo, a company specializing in performance-enhancing substances. Unlike common esterified forms of testosterone such as cypionate or enanthate, this formulation contains pure, unesterified testosterone crystals in a water-based medium. This allows for rapid absorption into the systemic circulation and immediate physiological activity, as the hormone does not require enzymatic cleavage of an ester to become active. It functions as a potent agonist of the androgen receptor (AR), promoting muscle protein synthesis, nitrogen retention, and the development of male secondary sexual characteristics. It is primarily utilized in non-therapeutic contexts for bodybuilding and athletic performance enhancement due to its rapid onset of action.

Brand names
SUSP-TESTO 100SUSP-TESTO100SUSP-TESTO-100
Other names
testosterone suspensionSinovo testosterone suspension
02

Targets

AR (Adrenergic receptors)

Beyond the preview

Go deeper on SUSP-TESTO 100.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SUSP-TESTO 100.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call